These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8864201)
1. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL. Colle CF; Tarbet EB; Grafton WD; Jennings SR; O'Callaghan DJ Virus Res; 1996 Aug; 43(2):111-24. PubMed ID: 8864201 [TBL] [Abstract][Full Text] [Related]
2. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge. Kim SK; Shakya AK; O'Callaghan DJ J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904 [TBL] [Abstract][Full Text] [Related]
3. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice. Smith PM; Kahan SM; Rorex CB; von Einem J; Osterrieder N; O'Callaghan DJ J Virol; 2005 Apr; 79(8):5105-15. PubMed ID: 15795295 [TBL] [Abstract][Full Text] [Related]
4. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11. von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719 [TBL] [Abstract][Full Text] [Related]
5. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Matsumura T; O'Callaghan DJ; Kondo T; Kamada M Vet Microbiol; 1996 Feb; 48(3-4):353-65. PubMed ID: 9054131 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D. Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356 [TBL] [Abstract][Full Text] [Related]
7. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D. Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146 [TBL] [Abstract][Full Text] [Related]
8. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection. Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864 [TBL] [Abstract][Full Text] [Related]
11. Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein E. Frampton AR; Smith PM; Zhang Y; Grafton WD; Matsumura T; Osterrieder N; O'Callaghan DJ Virus Genes; 2004 Aug; 29(1):9-17. PubMed ID: 15215680 [TBL] [Abstract][Full Text] [Related]
12. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. Frampton AR; Smith PM; Zhang Y; Matsumura T; Osterrieder N; O'Callaghan DJ Virus Res; 2002 Dec; 90(1-2):287-301. PubMed ID: 12457983 [TBL] [Abstract][Full Text] [Related]
13. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423 [TBL] [Abstract][Full Text] [Related]
14. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice. Marshall KR; Sun Y; Brown SM; Field HJ Virology; 1997 Apr; 231(1):20-7. PubMed ID: 9143298 [TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880 [TBL] [Abstract][Full Text] [Related]
16. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124 [TBL] [Abstract][Full Text] [Related]
17. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). Rudolph J; O'Callaghan DJ; Osterrieder N J Vet Med B Infect Dis Vet Public Health; 2002 Feb; 49(1):31-6. PubMed ID: 11911590 [TBL] [Abstract][Full Text] [Related]
18. Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha. Smith PM; Zhang Y; Grafton WD; Jennings SR; O'Callaghan DJ J Virol; 2000 Nov; 74(21):10034-40. PubMed ID: 11024132 [TBL] [Abstract][Full Text] [Related]
19. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice. Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744 [TBL] [Abstract][Full Text] [Related]
20. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model. Azmi M; Field HJ J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]